← Kiniksa Pharmaceuticals International, plc
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($1.5m) | ($64.9m) | ($103.2m) | ($161.9m) | ($161.4m) | ($157.9m) | $183.4m | $14.1m | ($43.2m) | $59.0m | — | |
| Depreciation and amortization | — | — | — | $2.1m | $2.4m | $2.4m | $2.4m | $2.3m | $1.7m | $1.6m | $1.8m | |
| Depreciation | — | $28k | $286k | $2.1m | $2.4m | $1.5m | $1.2m | $1.1m | $448k | $196k | $1.8m | |
| Net amortization (accretion) of discounts on short-term investments | — | — | ($1.4m) | ($3.5m) | $123k | $664k | ($82k) | ($1.1m) | $441k | ($916k) | — | |
| Amortization Of Securities | — | — | — | — | — | — | ($82k) | ($1.1m) | $441k | ($916k) | $1.1m | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $2.4m | $2.3m | $1.7m | $1.6m | $1.8m | |
| Deferred Income Tax Expense (Benefit) | — | ($197k) | ($978k) | ($3.2m) | $4.4m | $11k | ($185.5m) | ($33.8m) | $8.1m | $13.0m | $14.5m | |
| Deferred Tax | — | — | — | — | — | — | ($185.5m) | ($33.8m) | $8.1m | $13.0m | $14.5m | |
| Share-based Payment Arrangement, Noncash Expense | — | $897k | $5.7m | $15.1m | $20.9m | $25.2m | $25.1m | $27.1m | $30.7m | $37.0m | $42.1m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | $901k | $2.2m | $5.0m | $7.7m | — | |
| Share-based Payment Arrangement, Expense | — | $897k | $5.7m | $15.1m | $20.9m | $25.2m | $25.1m | $27.1m | $30.7m | $37.0m | $42.1m | |
| Share-based compensation expense | $0 | $897k | $5.7m | $15.1m | $20.9m | $25.2m | $25.1m | $27.1m | $30.7m | $37.0m | $42.1m | |
| Changes in operating assets and liabilities: | ||||||||||||
| Change In Working Capital | — | — | — | — | — | — | ($22.6m) | $1.4m | $24.8m | $24.8m | $41.0m | |
| Increase (Decrease) in Accounts Receivable | — | — | — | — | — | $3.9m | $8.7m | $8.6m | $20.5m | ($26.1m) | $8.4m | |
| Accounts receivable, net | — | — | — | — | — | ($3.9m) | ($8.7m) | ($8.6m) | ($20.5m) | $26.1m | $8.4m | |
| Change In Receivables | — | — | — | — | — | — | ($16.3m) | ($950k) | ($20.5m) | $26.1m | $8.4m | |
| Changes In Account Receivables | — | — | — | — | — | — | ($8.7m) | ($8.6m) | ($20.5m) | $26.1m | $8.4m | |
| Increase (Decrease) in Inventories | — | — | — | — | — | $3.7m | $17.9m | $9.5m | ($4.8m) | $28.5m | ($22.7m) | |
| Inventory | — | — | — | — | — | ($3.7m) | ($17.9m) | ($9.5m) | $4.8m | ($28.5m) | ($22.7m) | |
| Increase (Decrease) in Accounts Payable | $277k | $1.0m | $8.8m | ($4.7m) | ($5.0m) | $1.4m | $6.0m | $347k | ($6.3m) | $142k | $3.4m | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | $2.3m | $17.3m | $37.4m | $37.6m | $3.4m | |
| Accrued expenses, accrued collaboration expenses and other current liabilities | — | $4.1m | $9.3m | $4.6m | $8.8m | $10.3m | ($3.7m) | $16.9m | $43.7m | $37.5m | — | |
| Deferred revenue | — | — | — | — | — | — | $12.0m | $261k | $19.6m | — | — | |
| Additions to property and equipment included in accrued expenses and other liabilities | — | — | $1.3m | $222k | — | — | — | $54k | $153k | $83k | — | |
| Change In Accrued Expense | — | — | — | — | — | — | ($3.7m) | $16.9m | $43.7m | $37.5m | $48.7m | |
| Prepaid expenses and other current assets | ($4k) | ($1.2m) | ($4.8m) | ($1.0m) | ($1.3m) | $2.9m | ($3.9m) | ($7.1m) | ($2.7m) | ($22.5m) | — | |
| Change In Other Current Assets | — | — | — | — | — | — | $2.7m | $4.6m | ($9.7m) | ($1.2m) | ($2.8m) | |
| Change In Other Current Liabilities | — | — | — | — | — | — | ($1.4m) | ($3.2m) | ($4.0m) | $13.2m | $21.8m | |
| Net Cash Provided by (Used in) Operating Activities | ($882k) |
($50.2m)
-5591.43%
|
($81.0m)
-61.32%
|
($158.4m)
-95.49%
|
($136.5m)
+13.79%
|
($126.3m)
+7.50%
|
$5.8m
+104.60%
|
$13.3m
+129.05%
|
$25.7m
+93.14%
|
$138.0m
+437.14%
|
$185.0m
+34.05%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | — | $69k | $5.3m | $3.2m | $283k | $415k | $105k | $130k | $277k | $1.6m | ($2.1m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | ($66k) | ($21k) | — | ($103k) | ($33k) | ($179k) | ($1k) | $120k | ($128k) | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | $307.3m | $233.4m | $323.5m | $182.2m | $190.6m | $206.4m | $243.6m | $414.1m | — | |
| Debt Securities, Available-for-sale, Realized Gain (Loss) | — | — | — | — | — | — | — | — | $0 | $0 | — | |
| Purchases of short-term investments | — | — | ($402.0m) | ($488.8m) | ($430.2m) | ($157.2m) | ($135.9m) | ($204.9m) | ($202.0m) | ($386.9m) | — | |
| Proceeds from the maturities of short-term investments | — | — | $168.1m | $541.2m | $407.1m | $306.3m | $127.8m | $175.5m | $239.9m | $199.5m | — | |
| Net Cash Provided by (Used in) Investing Activities | $168k | ($69k) | ($239.2m) | $49.2m | ($23.4m) | $128.6m | ($8.1m) | ($29.6m) | $37.7m | ($189.0m) | ($239.1m) | |
| Cash flows from financing activities: | ||||||||||||
| Payments of Ordinary Dividends, Common Stock | — | $0 | $0 | — | — | — | — | — | — | — | — | |
| Common Stock Issuance | — | — | — | — | — | $0 | $3.4m | — | — | — | — | |
| Common Stock Payments | — | — | — | — | — | — | ($901k) | ($2.2m) | ($5.0m) | ($7.7m) | ($11.1m) | |
| Issuance Of Capital Stock | — | — | — | — | — | $0 | $3.4m | — | — | — | — | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($901k) | ($2.2m) | ($5.0m) | ($7.7m) | ($11.1m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($901k) | ($2.2m) | ($5.0m) | ($7.7m) | ($11.1m) | |
| Net Cash Provided by (Used in) Financing Activities | $730k |
$39.9m
+5363.39%
|
$346.7m
+769.60%
|
$84.1m
-75.74%
|
$227.1m
+170.00%
|
$5.9m
-97.41%
|
$2.5m
-57.25%
|
$1.5m
-40.58%
|
$12.3m
+720.47%
|
$33.0m
+169.22%
|
$37.7m
+14.28%
|
|
| Net increase (decrease) in cash and cash equivalents | — | ($10.4m) | $26.5m | ($25.0m) | $67.1m | $8.2m | $245k | ($14.8m) | $75.6m | ($18.0m) | — | |
| Cash and cash equivalents at beginning of period | — | $45.7m | $72.2m | $47.1m | $114.2m | $122.5m | $122.7m | $108.0m | $183.6m | $165.6m | — | |
| Beginning Cash Position | — | — | — | — | — | — | $122.5m | $122.7m | $108.0m | $183.6m | $192.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $45.7m | $72.2m | $47.1m | $114.2m | $122.5m | $122.7m | $108.0m | $183.6m | $165.6m | $175.7m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | — | — | $377k | $1.1m | $6.6m | $5.3m | $2.6m | $2.9m | — | — | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, Net | — | $290k | $383k | $1.7m | $482k | $1.3m | $10.7m | $5.6m | $2.0m | $3.0m | — | |
| Additional Financial Items | ||||||||||||
| General and Administrative Expense | — | $9.0m | $21.6m | $35.0m | $45.3m | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | — | $2k | ($214k) | ($2.0m) | $5.2m | $1.4m | ($172.3m) | ($30.7m) | $7.0m | $29.9m | — | |
| Investment Income, Interest | — | $529k | $4.7m | $6.0m | $1.1m | $97k | — | — | $9.0m | $11.6m | — | |
| Operating Expenses | — | $65.4m | $108.2m | $170.0m | $157.4m | — | — | — | — | — | — | |
| Non-cash lease expense | — | — | — | $1.2m | $1.4m | $2.6m | $3.0m | $3.1m | $3.1m | $3.7m | — | |
| Contract asset | — | — | — | — | — | — | ($7.7m) | $7.7m | — | — | — | |
| Other long-term assets | — | — | — | — | ($5.6m) | ($3.3m) | $2.7m | $4.6m | ($9.7m) | ($1.2m) | — | |
| Operating lease liabilities | — | — | — | ($1.3m) | ($1.7m) | ($2.6m) | ($3.0m) | ($3.3m) | ($4.0m) | ($3.5m) | — | |
| Other long-term liabilities | — | — | — | $326k | $478k | ($535k) | $1.6m | $19k | ($35k) | $16.7m | — | |
| Proceeds from issuance of Class A ordinary shares under incentive award plans and employee share purchase plan | — | — | — | $1.1m | $6.6m | $5.9m | $3.4m | $3.7m | $17.2m | $40.8m | — | |
| Payments in connection with ordinary stock tendered for employee tax obligations | — | — | — | — | — | — | ($901k) | ($2.2m) | ($5.0m) | ($7.7m) | — | |
| Change in right-of-use asset as a result of new, modified, and terminated leases | — | — | — | — | — | $1.6m | $2.9m | $9.6m | $1.6m | $3.1m | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $2.5m | $1.5m | $12.3m | $33.0m | $37.7m | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($8.1m) | ($29.6m) | $37.7m | ($189.0m) | ($239.1m) | |
| Change In Account Payable | — | — | — | — | — | — | $6.0m | $347k | ($6.3m) | $142k | $3.4m | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $245k | ($14.8m) | $75.6m | ($18.0m) | — | |
| Change In Other Working Capital | — | — | — | — | — | — | $12.0m | $261k | $19.6m | — | $19.6m | |
| Change In Payable | — | — | — | — | — | — | $6.0m | $347k | ($6.3m) | $142k | $3.4m | |
| Change In Prepaid Assets | — | — | — | — | — | — | ($3.9m) | ($7.1m) | ($2.7m) | ($22.5m) | ($15.8m) | |
| Changes In Cash | — | — | — | — | — | — | $245k | ($14.8m) | $75.6m | ($18.0m) | ($16.4m) | |
| End Cash Position | — | — | — | — | — | — | $122.7m | $108.0m | $183.6m | $165.6m | $175.7m | |
| Financing Cash Flow | — | — | — | — | — | — | $2.5m |
$1.5m
-40.58%
|
$12.3m
+720.47%
|
$33.0m
+169.22%
|
$37.7m
+14.28%
|
|
| Free Cash Flow | — | — | — | — | — | — | $5.7m | $13.2m | $25.4m | $136.4m | $182.8m | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | — | $33k | $179k | ($24k) | ($120k) | ($128k) | |
| Investing Cash Flow | — | — | — | — | — | — | ($8.1m) | ($29.6m) | $37.7m | ($189.0m) | ($239.1m) | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | ($20.0m) | $0 | $0 | — | — | — | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($8.1m) | ($29.4m) | $37.9m | ($187.4m) | ($236.9m) | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($14k) | ($130k) | ($252k) | ($1.6m) | ($2.1m) | |
| Operating Gains Losses | — | — | — | — | — | — | $33k | $179k | ($24k) | ($120k) | ($128k) | |
| Other Non Cash Items | — | — | — | — | — | — | $3.0m | $3.1m | $3.1m | $3.7m | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | $3.4m | $3.7m | $17.2m | $40.8m | $48.8m | |
| Purchase Of Intangibles | — | — | — | — | — | ($20.0m) | $0 | $0 | — | — | — | |
| Purchase Of Investment | — | — | — | — | — | — | ($135.9m) | ($204.9m) | ($202.0m) | ($386.9m) | ($544.2m) | |
| Purchase Of PPE | — | — | $5.3m | $3.2m | $283k | $415k | ($105k) | ($130k) | ($277k) | ($1.6m) | ($2.1m) | |
| Sale Of Investment | — | — | — | — | — | — | $127.8m | $175.5m | $239.9m | $199.5m | $307.2m | |
| Sale Of PPE | — | — | — | — | — | — | $91k | $0 | $25k | $0 | $0 | |
| Stock Based Compensation | — | — | — | — | — | — | $25.1m | $27.1m | $30.7m | $37.0m | $42.1m |